146 related articles for article (PubMed ID: 33173994)
1. NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer.
Lv S; Xu W; Zhang Y; Zhang J; Dong X
Int J Oncol; 2020 Dec; 57(6):1358-1367. PubMed ID: 33173994
[TBL] [Abstract][Full Text] [Related]
2. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.
Xu W; Wang Y; Wang Y; Lv S; Xu X; Dong X
Int J Mol Med; 2019 Aug; 44(2):390-404. PubMed ID: 31198978
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
4. Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression.
Huang Z; Li X; Xie T; Gu C; Ni K; Yin Q; Cao X; Zhang C
Cancer Res Treat; 2020 Oct; 52(4):1067-1083. PubMed ID: 32599985
[TBL] [Abstract][Full Text] [Related]
5. siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo.
Hu P; Chen X; Sun J; Bie P; Zhang LD
Biosci Rep; 2015 Jan; 35(1):. PubMed ID: 25370920
[TBL] [Abstract][Full Text] [Related]
6. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
[TBL] [Abstract][Full Text] [Related]
7. Silencing of NUF2 inhibits tumor growth and induces apoptosis in human hepatocellular carcinomas.
Liu Q; Dai SJ; Li H; Dong L; Peng YP
Asian Pac J Cancer Prev; 2014; 15(20):8623-9. PubMed ID: 25374179
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
[TBL] [Abstract][Full Text] [Related]
9. NUF2 Promotes Breast Cancer Development as a New Tumor Stem Cell Indicator.
Deng Y; Li J; Zhang Y; Hu H; Wan F; Min H; Zhou H; Gu L; Liao X; Zhou J; Zhou J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835637
[TBL] [Abstract][Full Text] [Related]
10. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
11. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
13. MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
Peng X; Yan B; Shen Y
Breast Cancer; 2018 Nov; 25(6):742-752. PubMed ID: 29951881
[TBL] [Abstract][Full Text] [Related]
14. SiRNA-mediated knockdown against NUF2 suppresses tumor growth and induces cell apoptosis in human glioma cells.
Huang SK; Qian JX; Yuan BQ; Lin YY; Ye ZX; Huang SS
Cell Mol Biol (Noisy-le-grand); 2014 Nov; 60(4):30-6. PubMed ID: 25481014
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.
Hu P; Shangguan J; Zhang L
Int J Clin Exp Pathol; 2015; 8(3):2638-48. PubMed ID: 26045769
[TBL] [Abstract][Full Text] [Related]
16. Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers.
Jiang X; Jiang Y; Luo S; Sekar K; Koh CKT; Deivasigamani A; Dong Q; Zhang N; Li S; Hao F; Goh BKP; Ooi LL; Wang Y; Hui KM
Cancer Res Treat; 2021 Oct; 53(4):944-961. PubMed ID: 33421974
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
[TBL] [Abstract][Full Text] [Related]
18. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Sun T; Song Y; Yu H; Luo X
Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of DHCR7 as a diagnostic biomarker involved in the proliferation and mitochondrial function of breast cancer.
Wang Y; Fan J; Liu Y; Du J; Liang B; Wang H; Song Z
Aging (Albany NY); 2024 Mar; 16(7):5967-5986. PubMed ID: 38526324
[TBL] [Abstract][Full Text] [Related]
20. MiR-940 promotes malignant progression of breast cancer by regulating FOXO3.
Zhang H; Peng J; Lai J; Liu H; Zhang Z; Li X; Liang B; Chen X; Zou B; Lin S; Zhang L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32840296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
